Michael R Hainstock, MD | |
1204 W Main St, Charlottesville, VA 22903-2824 | |
(434) 924-0123 | |
(434) 243-3300 |
Full Name | Michael R Hainstock |
---|---|
Gender | Male |
Speciality | Pediatrics - Pediatric Cardiology |
Location | 1204 W Main St, Charlottesville, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144547449 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0202X | Pediatrics - Pediatric Cardiology | 0101252220 (Virginia) | Primary |
Entity Name | Mcv Associated Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
Working in consultation with the United States Food and Drug Administration, McNeil Consumer Healthcare is implementing a voluntary recall of infant and children's liquid products due to manufacturing deficiencies which may affect quality, purity or potency.
These "surprising and significant findings" are reported in two studies from the Women's Health Initiative Memory Study, in which UC Medical Center participates, in today's issue of the Journal of the American Medical Association (JAMA).
Veterans of the Gulf War are more than twice as likely to have medically unexplained symptoms known as "multisymptom illness" (MSI), compared to Iraq/Afghanistan War veterans, according to an updated research review in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
A new study by researchers at Columbia University Mailman School of Public Health finds that folic acid supplements can dramatically lower blood arsenic levels in individuals exposed to arsenic through contaminated drinking water.
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies. On June 29, 2009, BioSante and Cell Genesys entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company.
› Verified 1 days ago
Entity Name | University Of Virginia Physicians Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
Working in consultation with the United States Food and Drug Administration, McNeil Consumer Healthcare is implementing a voluntary recall of infant and children's liquid products due to manufacturing deficiencies which may affect quality, purity or potency.
These "surprising and significant findings" are reported in two studies from the Women's Health Initiative Memory Study, in which UC Medical Center participates, in today's issue of the Journal of the American Medical Association (JAMA).
Veterans of the Gulf War are more than twice as likely to have medically unexplained symptoms known as "multisymptom illness" (MSI), compared to Iraq/Afghanistan War veterans, according to an updated research review in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
A new study by researchers at Columbia University Mailman School of Public Health finds that folic acid supplements can dramatically lower blood arsenic levels in individuals exposed to arsenic through contaminated drinking water.
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies. On June 29, 2009, BioSante and Cell Genesys entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Michael R Hainstock, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Michael R Hainstock, MD 1204 W Main St, Charlottesville, VA 22903-2824 Ph: (434) 924-0123 |
News Archive
Working in consultation with the United States Food and Drug Administration, McNeil Consumer Healthcare is implementing a voluntary recall of infant and children's liquid products due to manufacturing deficiencies which may affect quality, purity or potency.
These "surprising and significant findings" are reported in two studies from the Women's Health Initiative Memory Study, in which UC Medical Center participates, in today's issue of the Journal of the American Medical Association (JAMA).
Veterans of the Gulf War are more than twice as likely to have medically unexplained symptoms known as "multisymptom illness" (MSI), compared to Iraq/Afghanistan War veterans, according to an updated research review in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
A new study by researchers at Columbia University Mailman School of Public Health finds that folic acid supplements can dramatically lower blood arsenic levels in individuals exposed to arsenic through contaminated drinking water.
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies. On June 29, 2009, BioSante and Cell Genesys entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company.
› Verified 1 days ago
Mr. Michael Douglas Dickens, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1011 E Jefferson St, Charlottesville, VA 22902 Phone: 434-296-9161 Fax: 434-296-1036 | |
Linda A. Waggoner Fountain, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-0123 Fax: 434-243-3300 | |
Marion Elizabeth Szwedo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1011 E Jefferson St, Charlottesville, VA 22902 Phone: 434-296-9161 Fax: 434-977-6068 | |
Dr. Gregory Rees Sturz, DO, PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Box 800501, Charlottesville, VA 22908 Phone: 494-942-5321 Fax: 434-982-3816 | |
Anne C Butz, LCSW Pediatrics Medicare: Medicare Enrolled Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-5321 Fax: 434-244-4412 | |
Jessica C Di Zio, PNP Pediatrics Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-1761 Fax: 434-982-3561 | |
Brooke D. Vergales, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2335 Fax: 434-982-0796 |